Navigation Links
Sigma-Aldrich Corporation To Present At 32nd Annual J.P. Morgan Healthcare Conference
Date:12/19/2013

ST. LOUIS, Dec. 19, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced that Rakesh Sachdev, President and Chief Executive Officer, will be presenting at the 32nd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2014, in San Francisco at 2:30 PM (Pacific).

Interested parties may listen via live audio broadcast to the presentation over the internet at http://investor.sigmaaldrich.com/.  Users can click the "Webcast" icon to access this file. 

Interested parties may also view the presentation slides on the Company's investor relations website – http://investor.sigmaaldrich.com/.  The slides (titled "Investor Presentation") will be available on the website at or before the time of the Company's presentation at the conference.

About Sigma-Aldrich:  Sigma-Aldrich, a leading Life Science and High Technology company focused on enhancing human health and safety, manufactures and distributes more than 200,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets.  With three distinct business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is committed to enabling science to improve the quality of life.  The Company operates in 38 countries, has more than 9,000 employees worldwide and had sales of $2.6 billion in 2012.  For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.


'/>"/>
SOURCE Sigma-Aldrich Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Sigma-Aldrich (NASDAQ: SIAL) Reports Q3 2013 Sales Of $664 Million, Organic Sales Growth Of 5% And Adjusted Diluted EPS Of $1.05. Reaffirms Full Year 2013 Organic Sales Outlook. Narrows Adjusted Diluted EPS Outlook To A New Range Of $4.08 To $4.15
2. Sigma-Aldrich Announces Q3 2013 Earnings Conference Call
3. Sigma-Aldrich Corporation Delcares Quarterly Dividend Of $0.215 Per Share And Announces Election Of New Vice President And Treasurer
4. Sandia Biotech, Inc. and Sigma-Aldrich Enter into Global Distribution and Marketing Agreement
5. Sigma-Aldrich Corporation Presentations At Three Upcoming Conferences To Be Webcast Live
6. Sigma-Aldrich Corporation Declares Increased Quarterly Dividend; Announces Live Webcasts Of Presentations At Two Upcoming Conferences
7. Sigma-Aldrich Corporation Will Hold Its Annual Business Review March 21, 2013
8. Sigma-Aldrich Announces Q4 2012 Earnings Conference Call
9. Sigma-Aldrich Elects Michael Marberry As Director
10. Sigma-Aldrich Corporation Announces New Credit Facility
11. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Guggenheim Securities, the ... today announced the hiring of veteran equity analyst Charles ... analyst. Mr. Butler will focus on the biotech/biopharma sector. ... a wealth of experience and a broad network of ... Senior Managing Director and Head of Equities at Guggenheim ...
(Date:8/27/2014)... 27, 2014  ARCH Venture Partners, one of ... the development of seed and early-stage advanced technology ... closed with more than $400 million in subscriptions. ... subscription target by more than $150 million. ... strength and potential of our approach to finding ...
(Date:8/27/2014)... OR (PRWEB) August 27, 2014 According ... “Consolidation continues to reshape the look and feel of ... Consumer demand for higher-quality ingredients will push for more ... American market have experienced strong market growth in the ... attributes in their food and cosmetics to fit a ...
(Date:8/26/2014)... 26, 2014  NeuroSigma, Inc., a Los ... bioelectronic technologies, today announced that it has filed a ... and Exchange Commission relating to a proposed initial public ... to be offered and the price range for the ... Jefferies LLC will act as the book-running manager for ...
Breaking Biology Technology:Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3
... Greater Baltimore,Committee is seeking nominations for the Third ... on Tuesday, March 18, 2008. Those,interested in nominating ... http://www.gbc.org ., The four award categories are: ... and President,s Award. Nominators will,be asked to submit ...
... Jan. 14 VIRxSYS Corporation, a,privately held company ... Lentigen Corporation, a privately-owned biotechnology company,focused on the ... they have agreed to settle the pending litigation ... claims and counterclaims,asserted in the lawsuit, which has ...
... Company Accelerating Efforts to Commercialize Bio-Based Technologies to ... ... DuPont (NYSE: DD ),has named Nicholas C. Fanandakis group ... Fanandakis will lead the,company,s accelerated efforts to commercialize a range ...
Cached Biology Technology:VIRxSYS and Lentigen Announce Litigation Settlement 2DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences 2
(Date:8/27/2014)... beasts. But every creature is a baby once. , ... of 24 very young dinosaurs and one older individual ... a caretaker, according to a new study by University ... Peter Dodson led the work, collaborating with researchers from ... is held. Hedrick is a doctoral student in the ...
(Date:8/27/2014)... rare, but deadly disease that exists as five strains, ... most lethal strains is the Sudan ebolavirus (SUDV). Although ... caused widespread illness, even as recently as 2012. In ... Chemical Biology , researchers now report a possible therapy ... , John Dye, Sachdev Sidhu, Jonathan Lai and colleagues ...
(Date:8/27/2014)... the long-standing belief that a deficiency in serotonin ... central role in depression. In the journal ACS ... ability to make serotonin in their brains (and thus ... show depression-like symptoms. , Donald Kuhn and colleagues ... Wayne State University School of Medicine note that depression ...
Breaking Biology News(10 mins):Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2New study throws into question long-held belief about depression 2
... a gene for a specific protein face a 20-fold greater ... in mBio , the online open-access journal of the ... is the most common cause of fungal meningitis among HIV-infected ... HIV who has a very low level of CD4+ T ...
... at the Medical College of Wisconsin (MCW) have developed ... identify genetic mutations responsible for cancers.The tool, called DrGaP, ... the American Journal of Human Genetics . ... National Cancer Institute, and a former visiting scholar at ...
... FASEB MARC (Maximizing Access to Research Careers) Program ... Writing Seminar and Practical Exercises Workshop at the Marine ... 2012. Awards are given to graduate students, postdocs and ... have never written a successful grant application. This year ...
Cached Biology News:Gene makes some HIV-infected patients more at risk for fungal disease 2Gene makes some HIV-infected patients more at risk for fungal disease 3
Request Info...
... Nuclease catalyzes the degradation of single-stranded DNA ... products. While the nuclease prefers ssDNA over ... the enzyme degrades double-stranded DNA from both ... used for transcript mapping studies (3,4), for ...
... fosmid (40kb), and large plasmid insert (10-20kb) ... BAC vector. On command 20-50 fold copy ... DNA purification. Available with blue-white screening (pEZ ... the highest insert stability. Kits include electrocompetent ...
...
Biology Products: